T. M. Liew, C. S. Lee, K. L. Goh-shawn, and Z. Y. Chang, Potentially inappropriate prescribing among older persons: a meta-analysis of observational studies, Ann Fam Med, vol.17, pp.257-66, 2019.

D. Heider, H. Matschinger, A. D. Meid, R. Quinzler, J. B. Adler et al., Health service use, costs, and adverse events associated with potentially inappropriate medication in old age in Germany: retrospective matched cohort study, Drugs Aging, vol.34, pp.289-301, 2017.

D. S. Budnitz, M. C. Lovegrove, N. Shehab, and C. L. Richards, Emergency hospitalizations for adverse drug events in older Americans, N Engl J Med, vol.365, pp.2002-2014, 2011.

M. Pirmohamed, S. James, S. Meakin, C. Green, A. K. Scott et al., Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, vol.329, pp.15-24, 2004.

R. L. Maher, J. Hanlon, and E. R. Hajjar, Clinical consequences of polypharmacy in elderly, Expert Opin Drug Saf, vol.13, pp.57-65, 2014.

H. Autorité-de-santé, Comment améliorer la qualité et la sécurité des prescriptions de médicaments chez la personne âgée ?, 2019.

J. Ankri, Le risque iatrogène médicamenteux chez le sujet âgé, Gérontologie et société, vol.25, pp.93-106, 2002.

S. Ministère-des, L. De, and . Santé, La politique du médicament en EHPAD -Rapport, 2013.

A. Rousseau, M. C. Rybarczyk-vigouret, T. Vogel, P. O. Lang, and B. Michel, Inappropriate prescription and administration of medications in 10 nursing homes in Alsace, France. Rev Epidemiol Sante Publique, vol.64, pp.95-101, 2016.

L. Morin, M. L. Laroche, G. Texier, and K. Johnell, Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review, J Am Med Dir Assoc, vol.17, pp.862-863, 2016.

, Agence française de sécurité sanitaire des produits de santé. Prévenir la iatrogénèse médicamenteuse chez le sujet âgé, 2019.

H. Autorité-de-santé, Prescription médicamenteuse chez le sujet âgé (1) -Médecin traitant, 2019.

, Agence Nationale de l'Evaluation et de la qualité des Etablissements et Services sociaux et Médico-sociaux. Prise en charge médicamenteuse en EHPAD, 2019.

A. Desnoyer, B. Guignard, P. O. Lang, J. Desmeules, N. Vogt-ferrier et al., Prescriptions médicamenteuses potentiellement inappropriées en gériatrie : quels outils utiliser pour les détecter, Presse Med, vol.45, pp.957-70, 2016.

A. Boudon, F. Riat, Y. Rassam-hasso, and P. O. Lang, Polymorbidité et polypharmacie. Comment optimiser la prise en charge des patients âgés complexes, Forum Med Suisse, vol.17, pp.306-318, 2017.

G. Flodgren, A. Rachas, A. J. Farmer, M. Inzitari, and S. Shepperd, Interactive telemedicine: effects on professional practice and health care outcomes, Cochrane Database Syst Rev, p.2098, 2015.

A. A. Zulfiqar, A. Hajjam, S. Talha, M. Hajjam, J. Hajjam et al., Telemedicine and geriatrics in France: inventory of experiments, Curr Gerontol Geriatr Res, vol.2018, pp.1-10, 2018.

R. De-luca, A. Bramanti, M. C. De-cola, A. Trifiletti, P. Tomasello et al., Tele-health-care in the elderly living in nursing home: the first Sicilian multimodal approach, Aging Clin Exp Res, vol.28, pp.753-762, 2016.

P. Hanlon, L. Daines, C. Campbell, B. Mckinstry, D. Weller et al., Telehealth interventions to support self-Management of Long-Term Conditions: a systematic Metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer, J Med Internet Res, vol.19, p.172, 2017.

N. Bashi, M. Karunanithi, F. Fatehi, H. Ding, and D. Walters, Remote monitoring of patients with heart failure: an overview of systematic reviews, J Med Internet Res, vol.19, pp.1-14, 2017.

C. Trivalle, T. Cartier, C. Verny, A. M. Mathieu, P. Davrinche et al., IMEPAG GROUP Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects, J Nutr Health Aging, vol.14, pp.57-61, 2010.

K. R. Chapman, H. Bing-canar, M. L. Alosco, E. G. Steinberg, B. Martin et al., Mini mental state examination and logical memory scores for entry into Alzheimer's disease trials, Alzheimers Res Ther, vol.8, p.9, 2016.

Y. Rolland, S. Andrieu, C. Hein, and B. Vellas, Rates of admissions and discharges of nursing home residents in France: results of the pleiad study. La Revue de gériatrie, vol.37, pp.543-551, 2012.

M. Crotty, D. Rowett, L. Spurling, L. C. Giles, and P. A. Phillips, Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial, Am J Geriatr Pharmacother, vol.2, pp.257-64, 2004.

H. Autorité-de-santé, Mettre en oeuvre la conciliation des traitements médicamenteux en établissement de santé, 2019.

N. Luo, M. Li, C. J. Lloyd, A. Herdman, and M. , A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems, Qual Life Res, vol.22, pp.2237-2280, 2013.

I. N. Olssson, R. Runnamo, and P. Engfeldt, Medication quality and quality of life in the elderly, a cohort study, Health Qual Life Outcomes, vol.9, p.95, 2011.

L. Diguer, V. Turmel, J. Brin, T. Lapointe, S. Chrétien et al., Translation and validation in French of the Pathological Narcissism Inventory, Can J Behav Sci, 2019.

J. T. Hanlon and K. E. Schmader, The Medication Appropriateness Index at 20: where it started, where it has been and where it may be going, Drugs Aging, vol.30, p.10, 2013.

, Haute Autorité de Santé, guide «Choices in Methods for Economic Evaluation, 2019.

A. H. Briggs, Statistical approaches to handling uncertainty in health economic evaluation, Eur J Gastroenterol Hepatol, vol.16, pp.551-61, 2004.

. Correard, BMC Geriatrics, vol.20, p.147, 2020.

E. Fenwick, K. Claxton, and M. Sculpher, Representing uncertainty: the role of costeffectiveness acceptability curves, Health Econ, vol.10, pp.779-87, 2001.

J. Creswell and C. V. Plano, Designing and conducting mixed methods research, 2011.

M. Kaur, Application of mixed method approach in public Health Research, Indian J Community Med, vol.41, pp.93-100, 2016.

O. Santé and L. De, Rapport mondial sur le vieillissement et la santé, 2016.

L. , , 2019.

E. C. Lehnbom, M. J. Stewart, E. Manias, and J. I. Westbrook, Impact of medication reconciliation and review on clinical outcomes, Ann Pharmacother, vol.48, pp.1298-312, 2014.

M. Crotty, J. Halbert, D. Rowett, L. Giles, R. Birks et al., An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing, Age Ageing, vol.33, pp.612-619, 2004.

A. G. Zermansky, D. P. Alldred, D. R. Petty, D. K. Raynor, N. Freemantle et al., Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial, Age Ageing, vol.35, pp.586-91, 2006.

I. N. Olsson, B. Curman, and P. Engfeldt, Patient focused drug surveillance of elderly patients in nursing homes, Pharmacoepidemiol Drug Saf, vol.19, pp.150-157, 2010.

A. Mahlknecht, N. Nestler, U. Bauer, N. Schüßler, J. Schuler et al., Effect of training and structured medication review on medication appropriateness in nursing home residents and on cooperation between health care professionals: the InTherAKT study protocol, BMC Geriatr, vol.17, p.24, 2017.

O. Krause, B. Wiese, I. M. Doyle, C. Kirsch, P. Thürmann et al., HIOPP-3-iTBX study group. Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study), BMC Geriatr, vol.19, issue.2, 2019.

M. Gonzalvo, C. De-wit, H. A. Van-oijen, B. P. Hurkens, K. P. Janknegt et al., Supporting clinical rules engine in the adjustment of medication (SCREAM): protocol of a multicentre, prospective, randomised study, BMC Geriatr, vol.17, p.35, 2017.

I. D. Maidment, S. Damery, N. Campbell, N. Seare, C. Fox et al., Medication review plus person-centred care: a feasibility study of a pharmacy-health psychology dual intervention to improve care for people living with dementia, BMC Psychiatry, vol.18, 2018.

K. Cardwell, B. Clyne, F. Moriarty, E. Wallace, T. Fahey et al., Supporting prescribing in Irish primary care: protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care, Pilot Feasibility Stud, vol.4, p.122, 2018.

M. Wilchesky, G. Mueller, M. Morin, M. Marcotte, P. Voyer et al., The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study, BMC Geriatr, vol.18, p.204, 2018.

L. Desveaux, M. Saragosa, J. Rogers, L. Bevan, H. Loshak et al., Improving the appropriateness of antipsychotic prescribing in nursing homes: amixed-methods process evaluation of an academic detailing intervention, Implement Sci, vol.12, p.71, 2017.

W. H. Organization, Ethical issues related to study design for trials on therapeutics for Ebola Virus Disease: WHO Ethics Working Group meeting 20-21 October, summary of discussion

K. N. Van-dijk, D. Z. Van-asselt, D. Vogel, C. S. Van-der-hooft, E. N. Van-roon et al., Effects of a structured medication review by geriatrician and clinical pharmacologist on appropriateness of pharmacotherapy in frail elderly inpatients, Tijdschr Gerontol Geriatr, vol.40, pp.72-80, 2009.

S. Kaur, G. Mitchell, L. Vitetta, and M. S. Roberts, Interventions that can reduce inappropriate prescribing in the elderly: a systematic review, Drugs Aging, vol.26, pp.1013-1041, 2009.

R. J. Gillespie, L. Harrison, and J. Mullan, Deprescribing medications for older adults in the primary care context: a mixed studies review, Health Sci Rep, vol.1, p.45, 2018.

, Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

. Correard, BMC Geriatrics, vol.20, p.147, 2020.

, Annexe 3 : Mini Mental State Examination (MMSE) BIBLIOGRAPHIE

H. Autorité-de-santé, Guide méthodologique « Mettre en oeuvre la conciliation des traitements médicamenteux en établissement de santé », 2018.

H. Autorité-de-santé, Guide méthodologique « La conciliation des traitements médicamenteux en cancérologie, 2019.

S. Legrain, D. Bonnet-zamponi, and P. Saint-gaudens, La place de l'ETP dans la lutte contre l'iatrogénie médicamenteuse chez le sujet âgé polypathologique. Les cahiers de l'année gérontologique, vol.6, pp.177-86, 2014.

R. Santucci, D. Levêque, R. Herbrecht, M. Fischbach, A. C. Gérout et al., Évènements iatrogènes médicamenteux : impact des consultations pharmaceutiques en cours d'hospitalisation, Ann Pharm Fr, vol.72, issue.6, pp.440-50, 2014.

H. Autorité-de-santé, Prendre en charge une personne âgée polypathologique en soins primaires. Note méthodologique et de synthèse documentaire, 2015.

, Rapport de la commission d'études des problèmes de la vieillesse présidée par monsieur Pierre Laroque. La Documentation Française, pp.4-5, 1962.

, Direction de la Recherche, des Études, de l'Évaluation et des Statistiques (DREES). L'état de santé de la population en France, 2017.

, Agence Française de sécurité sanitaire des produits de santé (Afssaps), 2005.

P. Nair, N. Chalmers, L. Peterson, G. M. Bereznicki, B. J. Castelino et al., Hospitalization in older patients due to adverse drug reactions-the need for a prediction tool, Clin Interv Aging, vol.11, pp.497-505, 2016.

S. Legrain and . Haute-autorité-de-santé, Consommation médicamenteuse chez le sujet âgé, 2005.

J. Ankri, Le risque iatrogène médicamenteux chez le sujet âgé, Gerontol Soc, vol.103, issue.4, pp.93-106, 2002.

M. Monégat and C. Sermet, La polymédication : définitions, mesures et enjeux. Revue de la littérature et tests de mesure, vol.204, 2014.

A. Maladie, Améliorer la qualité du système de santé et maîtriser les dépenses -Rapport au ministre chargé de la Sécurité sociale et au Parlement sur l'évolution des charges et des produits de l'Assurance, 2018.

M. Herr, N. Sirven, H. Grondin, S. Pichetti, and C. Sermet, Fragilité des personnes âgées et consommation de médicaments : polymédication et prescriptions inappropriées. Institut de recherche et documentation en économie de la santé, p.230, 2018.

S. S. Mortazavi, M. Shati, A. Keshtkar, S. K. Malakouti, M. Bazargan et al., Defining polypharmacy in the elderly: a systematic review protocol, BMJ Open, vol.6, issue.3, 2016.

, Rapport à la Commission des comptes de la Sécurité sociale, Disponible sur, 2011.

A. Rousseau, M. C. Rybarczyk-vigouret, T. Vogel, P. Lang, and B. Michel, Inappropriate prescription and administration of medications in 10 nursing homes in Alsace, France. Rev Epidemiol Sante Publique, vol.64, issue.2, pp.95-101, 2016.

R. M. Goldberg, J. Mabee, L. Chan, and S. Wong, Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population, Am J Emerg Med, vol.14, issue.5, pp.447-50, 1996.

K. Viktil, H. Blix, T. Moger, and A. Reikvam, Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems, Br J Clin Pharmacol, vol.63, issue.2, pp.187-95, 2007.

C. Mazzocato, S. David, L. Benaroyo, and S. Monod, Polymédication et personne âgée : ni trop ni trop peu ! Rev Médicale Suisse, vol.9, pp.1026-1057, 2013.

J. H. Gurwitz, T. S. Field, L. R. Harrold, J. Rothschild, K. Debellis et al., Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting, JAMA, vol.289, issue.9, pp.1107-1123, 2003.

N. Leelakanok, A. L. Holcombe, B. C. Lund, X. Gu, and M. L. Schweizer, Association between polypharmacy and death: A systematic review and meta-analysis, J Am Pharm Assoc, vol.57, issue.6, pp.729-738, 2017.

E. Soto-perez-de-celis, D. Li, Y. Yuan, Y. M. Lau, and A. Hurria, Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer, Lancet Oncol, vol.19, issue.6, pp.305-321, 2018.

K. Mangerel, A. -. Branger, S. Rhalimi, and M. , Spécificités de la personne âgée et leurs conséquences sur la prise en charge médicamenteuse, vol.30, pp.167-73, 2011.

K. Turnheim, When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly, Exp Gerontol, vol.38, pp.843-53, 2003.

P. O. Lang, B. Boland, and O. Dalleur, Prescription médicamenteuse inappropriée : les nouveaux critères STOPP/START, vol.11, pp.2115-2138, 2015.

M. Bo, V. Quaranta, G. Fonte, Y. Falcone, G. Carignano et al., Prevalence, predictors and clinical impact of potentially inappropriate prescriptions in hospital-discharged older patients: A prospective study, Geriatr Gerontol Int, vol.18, issue.4, pp.561-569, 2018.

P. A. Rochon and J. H. Gurwitz, Drug therapy, Lancet Lond Engl, vol.346, issue.8966, pp.32-38, 1995.

P. A. Rochon and J. H. Gurwitz, Optimising drug treatment for elderly people: the prescribing cascade, BMJ, vol.315, issue.7115, pp.1096-1105, 1997.

L. M. Mccarthy, J. D. Visentin, and P. A. Rochon, Assessing the Scope and Appropriateness of Prescribing Cascades, J Am Geriatr Soc, vol.67, issue.5, pp.1023-1029, 2019.

D. O'mahony and P. F. Gallagher, Inappropriate prescribing in the older population: need for new criteria, Age Ageing, vol.37, issue.2, pp.138-179, 2008.

M. H. Beers, J. G. Ouslander, I. Rollingher, D. B. Reuben, J. Brooks et al., Explicit criteria for determining inappropriate medication use in nursing home residents, Arch Intern Med, vol.151, issue.9, pp.1825-1857, 1991.

M. H. Beers, Explicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update, Arch Intern Med, vol.157, issue.14, pp.1531-1537, 1997.

D. M. Fick, J. W. Cooper, W. E. Wade, J. L. Waller, J. R. Maclean et al., Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts, Arch Intern Med, vol.163, issue.22, pp.2716-2740, 2003.

, The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, J Am Geriatr Soc, vol.60, issue.4, pp.616-647, 2012.

, Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, American Geriatrics Society, vol.67, issue.4, pp.674-94, 2019.

C. Zhan, J. Sangl, A. S. Bierman, M. R. Miller, B. Friedman et al., Potentially Inappropriate Medication Use in the Community-Dwelling Elderly: Findings From the 1996 Medical Expenditure Panel Survey, JAMA, vol.286, issue.22, pp.2823-2832, 2001.

P. Mcleod, A. Huang, R. Tamblyn, and D. Gayton, Defining inappropriate practices in prescribing for elderly people: A national consensus panel, Can Med Assoc J, vol.156, pp.385-91, 1997.

D. Fialová, E. Topinková, G. Gambassi, H. Finne-soveri, P. V. Jónsson et al., Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe

, JAMA, vol.293, issue.11, pp.1348-58, 2005.

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, Eur J Clin Pharmacol, vol.63, issue.8, pp.725-756, 2007.

M. Laroche, F. Bouthier, M. L. Charmes, and J. , Médicaments potentiellement inappropriés aux personnes âgées : intérêt d'une liste adaptée à la pratique médicale française, Rev Médecine Interne, vol.30, issue.7, pp.592-601, 2009.

S. Basnet, M. Zhang, M. Lesser, G. Wolf-klein, G. Qiu et al., Thirty-day hospital readmission rate amongst older adults correlates with an increased number of medications, but not with Beers medications, Geriatr Gerontol Int, vol.18, issue.10, pp.1513-1521, 2018.

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, D. O'mahony et al., Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation, Int J Clin Pharmacol Ther, vol.46, pp.72-83, 2008.

O. Dalleur, P. O. Lang, and B. Boland, La nouvelle version des critères STOPP/START adaptée en français, vol.49, pp.61-64, 2016.

B. Hill-taylor, I. Sketris, J. Hayden, S. Byrne, D. O'sullivan et al., Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact, J Clin Pharm Ther, vol.38, issue.5, pp.360-72, 2013.

B. Boland, . Stopp, and . Start, v2 : un outil à jour pour la qualité de la prescription chez les patients âgés de 65 ans et plus, Louvain Méd, vol.134, pp.219-242, 2015.

P. Gallagher, M. O'connor, O. 'mahony, and D. , Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria, Clin Pharmacol Ther, vol.89, pp.845-54, 2011.

A. Frey-geoffret, Critères STOPP/START version 2 : étude de faisabilité de l'utilisation d'une version informatisée en médecine générale, 2016.

A. Desnoyer, A. Blanc, V. Pourcher, M. Besson, C. Fonzo-christe et al.,

. Pim-check, development of an international prescription-screening checklist designed by a Delphi method for internal medicine patients, BMJ Open, vol.7, issue.7, 2017.

A. Desnoyer, Elaboration d'un outil de détection des prescriptions inappropriées destiné aux adultes en médecine interne, p.67, 2014.

S. Spasojevic, A. Blanc, A. Leszek, M. Théodoloz, T. Fumeaux et al., Prescription médicamenteuse potentiellement inappropriée en médecine interne générale : comparaison de STOPP/START et PIM-Check©, Pharm Hosp Clin, vol.52, issue.1, 2017.

F. Puisieux, D. 'andrea, C. Baconnier, P. Bui-dinh, D. Castaings-pelet et al., Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly, Rev Mal Respir, vol.28, issue.8, pp.76-93, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00727238

B. Allenet, M. Juste, C. Mouchoux, R. Collomp, X. Pourrat et al., De la dispensation au plan pharmaceutique personnalisé : vers un modèle intégratif de pharmacie clinique, Pharm Hosp Clin, vol.54, issue.1, pp.56-63, 2019.

. Société-française-de-pharmacie-clinique, Préconisations pour la pratique de conciliation des traitements médicamenteux, 2015.

A. Mekonnen, A. Mclachlan, and J. Brien, Pharmacy-led medication reconciliation programmes at hospital transitions: A systematic review and meta-analysis, J Clin Pharm Ther, 2016.

S. K. Mueller, K. C. Sponsler, S. Kripalani, and J. L. Schnipper, Hospital-based medication reconciliation practices: a systematic review, Arch Intern Med, vol.172, issue.14, pp.1057-69, 2012.

J. L. Kwan, L. Lo, M. Sampson, and K. G. Shojania, Medication reconciliation during transitions of care as a patient safety strategy: a systematic review, Ann Intern Med, vol.158, issue.5, pp.397-403, 2013.

D. Bates, N. Spell, D. Cullen, E. Burdick, N. Laird et al., The Costs of Adverse Drug Events in Hospitalized Patients, JAMA, vol.277, pp.307-318, 1998.

H. Chayé, M. Bernard, M. Tubéry, V. Rousseau, M. Ecoiffier et al., Réhospitalisations d'origine médicamenteuse : étude pilote dans un service de posturgences médicales d'un hôpital universitaire français, Rev Médecine Interne, vol.36, issue.7, pp.450-456, 2015.

S. Dobrzanski, I. Hammond, G. Khan, and H. Holdsworth, The nature of hospital prescribing errors, Br J Clin Gov, vol.7, issue.3, pp.187-93, 2002.

V. C. Tam, S. R. Knowles, P. L. Cornish, N. Fine, R. Marchesano et al., Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review, CMAJ, vol.173, issue.5, pp.510-515, 2005.

P. L. Cornish, S. R. Knowles, R. Marchesano, V. Tam, S. Shadowitz et al.,

, Unintended Medication Discrepancies at the Time of Hospital Admission, Arch Intern Med, vol.165, issue.4, pp.424-433, 2005.

P. Saint-germain, M. Ruelle, M. A. , S. Idris, S. Hannat et al., Impact clinique des divergences de traitement constatées chez 200 patients conciliés dans un service de gériatrie aiguë, Rev Médecine Interne, vol.37, issue.10, pp.667-73, 2016.

J. D. Wong, J. M. Bajcar, G. G. Wong, S. M. Alibhai, J. Huh et al., Medication Reconciliation at Hospital Discharge: Evaluating Discrepancies, Ann Pharmacother, vol.42, issue.10, pp.1373-1382, 2008.

J. L. Schnipper, J. L. Kirwin, M. C. Cotugno, S. A. Wahlstrom, B. A. Brown et al., Role of pharmacist counseling in preventing adverse drug events after hospitalization, Arch Intern Med, vol.166, issue.5, pp.565-71, 2006.

L. Andreoli, A. Tesmoingt, C. Eerdekens, C. Macrez, A. Papo et al., Medication Reconciliation: A Prospective Study in an Internal Medicine Unit, Drugs Aging, vol.31, issue.5, pp.387-93, 2014.

G. Leguelinel-blache, F. Arnaud, S. Bouvet, F. Dubois, C. Castelli et al., Impact of admission medication reconciliation performed by clinical pharmacists on medication safety, Eur J Intern Med, vol.25, issue.9, pp.808-822, 2014.

A. Monfort, N. Curatolo, T. Begue, A. Rieutord, and S. Roy, Medication at discharge in an orthopaedic surgical ward: quality of information transmission and implementation of a medication reconciliation form, Int J Clin Pharm, vol.38, issue.4, pp.838-885, 2016.

A. H. Salanitro, C. Y. Osborn, J. L. Schnipper, C. L. Roumie, S. Labonville et al., Effect of patient-and medication-related factors on inpatient medication reconciliation errors, J Gen Intern Med, vol.27, issue.8, pp.924-956, 2012.

T. Grimmsmann, U. Schwabe, and W. Himmel, The influence of hospitalisation on drug prescription in primary care -a large-scale follow-up study, Eur J Clin Pharmacol, vol.63, issue.8, pp.783-90, 2007.

M. Pérennes, A. Carde, X. Nicolas, M. Dolz, R. Bihannic et al., Conciliation médicamenteuse : une expérience innovante dans un service de médecine interne pour diminuer les erreurs d'anamnèse médicamenteuses, Presse Médicale, vol.41, issue.3, pp.77-86, 2012.

R. A. Cochrane, A. R. Mandal, M. Ledger-scott, and R. Walker, Changes in drug treatment after discharge from hospital in geriatric patients, BMJ, vol.305, issue.6855, pp.694-700, 1992.

K. Viktil, H. Blix, A. Eek, M. Davies, T. Moger et al., How are drug regimen changes during hospitalisation handled after discharge: A cohort study, BMJ Open, vol.2, 2012.

C. Pichat, Évolution de l'ordonnance des patients a un mois de la sortie d'un service de médecine polyvalente, Montpellier, vol.1, 2013.

S. Kripalani, F. Lefevre, C. Phillips, M. Williams, P. Basaviah et al., Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians, JAMA J Am Med Assoc, vol.297, pp.831-872, 2007.

O. Krause, S. Glaubitz, K. Hager, T. Schleef, B. Wiese et al., Post-discharge adjustment of medication in geriatric patients, Z Für Gerontol Geriatr, 2019.

X. Pourrat, C. Roux, B. Bouzige, V. Garnier, A. Develay et al., Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: Study protocol for a randomized controlled trial, Trials, vol.15, p.260, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02007513

P. Renaudin, K. Baumstarck, A. Daumas, M. Estève, S. Gayet et al., Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: Study protocol for a randomized open-label controlled trial, Trials, vol.18, p.65, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01478931

, 728 000 résidents en établissements d'hébergement pour personnes âgées en 2015, des Études, de l'Évaluation et des Statistiques (DREES), 2017.

P. Verger, Ministère des affaires sociales et de la santé

, Agence nationale de l'évaluation et de la qualité des établissements et services sociaux et médico-sociaux. Prise en charge médicamenteuse en EHPAD. Fiche-repère, 2016.

L. Morin, M. Laroche, G. Texier, and K. Johnell, Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review, J Am Med Dir Assoc, vol.17, issue.9, p.862, 2016.

S. Handler, R. Wright, C. Ruby, and J. Hanlon, Epidemiology of medication-related adverse events in nursing homes, Am J Geriatr Pharmacother, vol.4, pp.264-72, 2006.

H. Autorité-de-santé, Comment réduire les hospitalisations non programmées des résidents en EHPAD, 2015.

Y. Roland, Nos aînés fragilisés en maison de retraite médicalisée : une vie de mouvements? Présentation de la 1ère étude française quantifiant l'importance des transferts hospitaliers dans les maisons de retraite médicalisées et leurs conséquences. Nouvelles données, nouveaux profils, vers quelles perspectives ? Étude Pleiad, Gérontopôle Toulouse, 2010.

B. Graverholt, L. Forsetlund, and G. Jamtvedt, Reducing hospital admissions from nursing homes: A systematic review, BMC Health Serv Res, vol.14, 2014.

L. Fur-musquer, E. Delamarre-damier, F. , D. Decker, L. et al., Modalités d'hospitalisations en urgence des sujets âgés hébergés en établissements pour personnes âgées dépendantes, Geriatr Psychol Neuropsychiatr Vieil, vol.9, issue.4, pp.409-424, 2011.

K. Pearson, Emergency Transfers of the Elderly from Nursing Facilities to Critical Access Hospitals: Opportunities for Improving Patient Safety and Quality, vol.32, pp.1-10, 2013.

H. Autorité-de-santé, Prescrire chez le sujet âgé (plus de 75 ans ou plus de 65 ans et polypathologique), 2006.

R. Luca, A. Bramanti, M. C. De-cola, A. Trifiletti, P. Tomasello et al., Tele-healthcare in the elderly living in nursing home: the first Sicilian multimodal approach, Aging Clin Exp Res, vol.28, issue.4, pp.753-762, 2015.

P. Hanlon, L. Daines, C. Campbell, B. Mckinstry, D. Weller et al., Telehealth interventions to support self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease and cancer, J Med Internet Res, vol.19, issue.5, 2017.

A. Zulfiqar, A. Hajjam, S. Talha, M. Hajjam, H. Jawad et al., Telemedicine and Geriatrics in France: Inventory of Experiments, Curr Gerontol Geriatr Res, 2018.

K. Dijk, D. Van-asselt, D. Vogel, C. Hooft, E. Roon et al., Effects of a structured medication review by geriatrician and clinical pharmacologist on appropriateness of pharmacotherapy of frail elderly inpatients, Tijdschr Gerontol Geriatr, vol.40, pp.72-80, 2009.

S. Kaur, G. Mitchell, L. Vitetta, and M. Roberts, Interventions that can Reduce Inappropriate Prescribing in the Elderly: A Systematic Review, Drugs Aging, vol.26, pp.1013-1041, 2009.

B. Allenet, D. Cabelguenne, A. Lepelletier, S. Prot-labarthe, C. Mouchoux et al., Le plan pharmaceutique personnalisé et le nouveau modèle de pharmacie clinique, Le Pharmacien Hospitalier et Clinicien, vol.52, issue.3, pp.306-315, 2017.

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, Mini-mental state": A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, issue.3, pp.189-98, 1975.

C. Trivalle and P. Ducimetière, Effets indésirables des médicaments : score de risque en gériatrie, NPG Neurol -Psychiatr -Gériatrie, vol.13, issue.74, pp.101-107, 2013.

I. N. Olsson, R. Runnamo, and P. Engfeldt, Medication quality and quality of life in the elderly, a cohort study, Health Qual Life Outcomes, vol.95, pp.1-9, 2011.